CDC Endorsement of Single Dose Antibiotic for Lyme Disease Prevention Challenged
Advocates claim policy harms patients and violates HHS standards for information quality
Washington, DC – WEBWIRE – Tuesday, February 19, 2019
Advocates for Lyme disease patients are calling on the Centers for Disease Control and Prevention (CDC) to withdraw its endorsement of single-dose antibiotic prophylaxis for prevention of Lyme disease after a tick bite.
A key limitation of the recommendation is that it is based on a single study that has not been replicated and which did not prove that the prophylaxis actually prevented Lyme disease. In addition, the recommendation is restrictive since it is only recommended if certain criteria are met. This is likely to confuse both the public and health care providers.